The leader of Honeywell International Inc.’s aerospace group says the $15 billion operation is still wrestling with problems in its supply chain even as it’s been steadily ramping production. “The ...
Where the field convenes. Privately. A curated private community for credentialed ethics, risk, and compliance leaders across the ECI and Compliance Week network. Ask the questions you can’t post ...
Titaner is a company that has been producing titanium everyday carry (EDC) gear for more than 20 years. Its products typically focus on compact form, durability, and smart mechanical design. Its ...
From matcha lattes to pistachio-studded Dubai chocolate, ingredient trends quickly evolve from niche to viral with just a few clicks. But, the challenge for brands isn’t just identifying the next ...
The global chip sector is under heightened pressure around supply chains and costs as the fallout from the Iran war continues. While an AI rally continues to boost stocks, a prolonged conflict would ...
Four supply-chain incidents hit OpenAI, Anthropic and Meta in 50 days: three adversary-driven attacks and one self-inflicted packaging failure. None targeted the model, and all four exposed the same ...
The UK continues to experience shortages of many common prescription drugs, despite efforts to strengthen supply chains. As products become unavailable, pressure increases across the system to secure ...
m[i, j] = 0 nếu i = j m[i, j] = min { m[i, k] + m[k+1, j] + p[i-1]·p[k]·p[j] } nếu i < j i ≤ k < j ...
Starbucks (SBUX) is the largest coffee chain in the U.S. but no longer accounts for more than 50% of all chain coffee store sales like it did in 2023. Established chains Dunkin, Panera (PANERA), ...
Pull apart any consumer electronics product, and you will likely find the same class of components that investigators are now pulling out of Russian weapons systems: power diodes, MOSFETs, rectifiers.
A recently published paper delivers a finding that should be well known to every executive in Western pharma: China has gone from accounting for less than 8% of global clinical trials in 2010 to ...
What starts as one issue quickly turns into problem after problem in the field. The breakdowns, frustration, and constant setbacks make it clear why plowing is no longer worth the trouble. US fired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results